| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PERRIGO Co plc | Director | Ordinary Shares | 30,637 | $796,868 | $26.01 | 14 May 2025 | Direct |
| Theravance Biopharma, Inc. | Director | Ordinary Shares | 74,204 | $723,489 | $9.75 | 19 May 2025 | Direct |
| PERRIGO Co plc | Director | Ordinary Shares | 1,198 | $30,692 | $25.62 | 14 May 2025 | by Approved Retirement Fund |
| Theravance Biopharma, Inc. | Director | Share Option (Right to Buy) | 24,258 | 19 May 2025 | Direct | ||
| PERRIGO Co plc | Director | Restricted Stock Units | 0 | 14 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | 19 May 2025 | 2 | $0 | 4 | Director | 21 May 2025, 19:17 |
| PRGO | PERRIGO Co plc | 14 May 2025 | 4 | +$133,952 | 4 | Director | 16 May 2025, 11:52 |
| PRGO | PERRIGO Co plc | 14 May 2024 | 4 | +$137,713 | 4 | Director | 16 May 2024, 19:28 |
| TBPH | Theravance Biopharma, Inc. | 08 May 2024 | 2 | $0 | 4 | Director | 10 May 2024, 18:10 |
| PRGO | PERRIGO Co plc | 17 May 2023 | 3 | +$132,886 | 4 | Director | 19 May 2023, 14:38 |
| PRGO | PERRIGO Co plc | 15 May 2023 | 1 | $0 | 4 | Director | 17 May 2023, 20:14 |
| TBPH | Theravance Biopharma, Inc. | 02 May 2023 | 2 | $0 | 4 | Director | 04 May 2023, 18:46 |
| TBPH | Theravance Biopharma, Inc. | 22 Nov 2022 | 1 | -$105,000 | 4 | Director | 23 Nov 2022, 17:57 |
| PRGO | PERRIGO Co plc | 17 May 2022 | 4 | +$132,334 | 4 | Director | 19 May 2022, 13:54 |
| TBPH | Theravance Biopharma, Inc. | 26 Apr 2022 | 2 | $0 | 4 | Director | 28 Apr 2022, 21:18 |
| PRGO | PERRIGO Co plc | 17 May 2021 | 1 | $0 | 4 | Director | 19 May 2021, 12:59 |
| PRGO | PERRIGO Co plc | 07 May 2021 | 3 | +$129,653 | 4 | Director | 11 May 2021, 14:56 |